Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...
The cost of cancer may be higher than previously estimated, according to a recent report from the American Cancer Society.
which has already got a biosimilar to Roche’s Avastin (bevacizumab) cancer drug backed by the FDA. Amgen already has a biosimilar of AbbVie’s Humira (adalimumab) approved in the US ...
The Hill on MSN13d
Biden administration picks 15 more drugs for Medicare negotiationThe drugs treat conditions such as diabetes and cancer, and seniors across the country rely on ... including those that have ...
The global biosimilars market size was valued at USD 28.70 billion in 2024 and is projected to reach from USD 33.16 billion ...
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...
Johnson amp Johnson exceeded Wall Street expectations for fourth-quarter revenue and profit with robust sales of cancer ...
Josh Gissing is Cluster Head (UK, Ireland & Nordics) for Biocon Biologics: a biosimilars company whose business model seeks ...
Johnson & Johnson exceeded Wall Street expectations for fourth-quarter revenue and profit, with robust sales of cancer treatments leading the charge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback